tiprankstipranks
TOT BIOPHARM International Co. Ltd. (HK:1875)
:1875
Hong Kong Market

TOT BIOPHARM International Co. Ltd. (1875) Income Statement

Compare
0 Followers

TOT BIOPHARM International Co. Ltd. Income Statement

Last quarter (Q2 2024), TOT BIOPHARM International Co. Ltd.'s total revenue was ¥520.60M, an increase of 186.02% from the same quarter last year. In Q2, TOT BIOPHARM International Co. Ltd.'s net income was ¥31.56M. See TOT BIOPHARM International Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 780.63M¥ 442.18M¥ 76.33M¥ 22.49M¥ 45.31M
Gross Profit
¥ 573.99M¥ 370.62M¥ 27.47M¥ 15.53M¥ 33.99M
Operating Expenses
¥ 607.05M¥ 409.45M¥ 282.93M¥ 305.27M¥ 305.49M
Depreciation and Amortization
¥ 43.03M¥ 38.04M¥ 34.24M¥ 32.08M¥ 27.35M
EBITDA
¥ 10.45M¥ -5.41M¥ -224.51M¥ -254.71M¥ -240.07M
Operating Income
¥ -33.06M¥ -39.08M¥ -259.70M¥ -288.67M¥ -271.50M
Other Income/Expenses
¥ -4.70M¥ -10.97M¥ -1.52M¥ 174.00K¥ -29.70M
Pretax Income
¥ -37.76M¥ -50.05M¥ -261.22M¥ -288.50M¥ -299.30M
Net Income
¥ -37.76M¥ -49.92M¥ -261.22M¥ -288.50M¥ -331.18M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -0.05¥ -0.08¥ -0.46¥ -0.51¥ -0.99
Diluted EPS
¥ -0.05¥ -0.08¥ -0.46¥ -0.51¥ -0.99
Weighted Average Shares Outstanding
725.20M 639.31M 573.36M 570.33M 335.65M
Weighted Average Shares Outstanding (Diluted)
725.20M 639.31M 573.36M 570.33M 335.65M
Currency in CNY

TOT BIOPHARM International Co. Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis